Regulation of genes involved in carnitine homeostasis by PPAR α across different species (rat, mouse, pig, cattle, chicken, and human)

PPAR Research

Volumn , Issue , 2012, Pages

  Ringseis, Robert ^a   Wen, Gaiping ^a   Eder, Klaus ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE I; CLOFIBRATE; ETOFIBRATE; FENOFIBRATE; GAMMA BUTYROBETAINE; GEMFIBROZIL; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2;

BIOSYNTHESIS; CARNITINE DEFICIENCY; DIETARY INTAKE; DISEASE SEVERITY; DRUG BIOAVAILABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HUMAN; LACTATION; LIPID METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PROCESSING; REVIEW; SINGLE DRUG DOSE; THIRD TRIMESTER PREGNANCY; TREADMILL EXERCISE; UPREGULATION; URINARY EXCRETION; VITAMIN SUPPLEMENTATION;

EID: 84870228309     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/868317     Document Type: Review

References (91)

1. Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 1999 20 5 649 688 2-s2.0-0033305213 (Pubitemid 30650602)
2. Mandard S., Müller M., Kersten S., Peroxisome proliferator-activated receptor α target genes. Cellular and Molecular Life Sciences 2004 61 4 393 416 2-s2.0-1542283630 10.1007/s00018-003-3216-3 (Pubitemid 38316578)
3. Schoonjans K., Martin G., Staels B., Auwerx J., Peroxisome proliferator-activated receptors, orphans with ligands and functions. Current Opinion in Lipidology 1997 8 3 159 166 2-s2.0-0030794057 10.1097/00041433- 199706000-00006 (Pubitemid 27290462)
4. McGarry J. D., Robles Valdes C., Foster D. W., Role of carnitine in hepatic ketogenesis. Proceedings of the National Academy of Sciences of the United States of America 1975 72 11 4385 4388 2-s2.0-0001354342
5. Brass E. P., Hoppell C. L., Carnitine metabolism in the fasting rat. Journal of Biological Chemistry 1978 253 8 2688 2693 2-s2.0-0017876814 (Pubitemid 8328428)
6. Paul H. S., Adibi S. A., Paradoxical effects of clofibrate on liver and muscle metabolism in rats. Induction of myotonia and alteration of fatty acid and glucose oxidation. Journal of Clinical Investigation 1979 64 2 405 412 2-s2.0-0018744514 (Pubitemid 9234984)
7. Paul H. S., Gleditsch C. E., Adibi S. A., Mechanism of increased hepatic concentration of carnitine by clofibrate. American Journal of Physiology 1986 251 3 E311 E315 2-s2.0-0022451896
8. Luci S., Geissler S., König B., Koch A., Stangl G. I., Hirche F., Eder K., PPAR α agonists up-regulate organic cation transporters in rat liver cells. Biochemical and Biophysical Research Communications 2006 350 3 704 708 2-s2.0-33749648743 10.1016/j.bbrc.2006.09.099 (Pubitemid 44547904)
9. van Vlies N., Ferdinandusse S., Turkenburg M., Wanders R. J. A., Vaz F. M., PPAR α -activation results in enhanced carnitine biosynthesis and OCTN2-mediated hepatic carnitine accumulation. Biochimica et Biophysica Acta 2007 1767 9 1134 1142 2-s2.0-34548151116 10.1016/j.bbabio.2007.07.001 (Pubitemid 47313393)
10. Koch A., König B., Stangl G. I., Eder K., PPAR α mediates transcriptional upregulation of novel organic cation transporters-2 and -3 and enzymes involved in hepatic carnitine synthesis. Experimental Biology and Medicine 2008 233 3 356 365 2-s2.0-40149101595 10.3181/0706-RM-168 (Pubitemid 351328577)
11. Wen G., Ringseis R., Eder K., Mouse OCTN2 is directly regulated by peroxisome proliferator-activated receptor α (PPAR α) via a PPRE located in the first intron. Biochemical Pharmacology 2010 79 5 768 776 2-s2.0-71849088563 10.1016/j.bcp.2009.10.002
12. Wen G., Kühne H., Rauer C., Ringseis R., Eder K., Mouse γ -butyrobetaine dioxygenase is regulated by peroxisome proliferator-activated receptor α through a PPRE located in the proximal promoter. Biochemical Pharmacology 2011 82 2 175 183 2-s2.0-79958097551 10.1016/j.bcp.2011.04.006
13. Wen G., Ringseis R., Rauer C., Eder K., The mouse gene encoding the carnitine biosynthetic enzyme 4-N-trimethylaminobutyraldehyde dehydrogenase is regulated by peroxisome proliferator-activated receptor α Biochimica et Biophysica Acta 2012 1819 5 357 365 2-s2.0-84857470016 10.1016/j.bbagrm.2012.01. 004
14. Richert L., Price S., Chesne C., Maita K., Carmichael N., Comparison of the induction of hepatic peroxisome proliferation by the herbicide oxadiazon in vivo in rats, mice, and dogs and in vitro in rat and human hepatocytes. Toxicology and Applied Pharmacology 1996 141 1 35 43 2-s2.0-0030296421 10.1006/taap.1996.0257 (Pubitemid 26414347)
15. Johnson E. F., Hsu M. H., Savas U., Griffin K. J., Regulation of P450 4A expression by peroxisome proliferator activated receptors. Toxicology 2002 181-182 203 206 2-s2.0-0037184821 10.1016/S0300-483X(02)00282-2 (Pubitemid 36015699)
16. Perrone C. E., Shao L., Williams G. M., Effect of rodent hepatocarcinogenic peroxisome proliferators on fatty acyl-CoA oxidase, DNA synthesis, and apoptosis in cultured human and rat hepatocytes. Toxicology and Applied Pharmacology 1998 150 2 277 286 2-s2.0-0032102436 10.1006/taap.1998.8413 (Pubitemid 28302511)
17. Ammerschlaeger M., Beigel J., Klein K. U., Mueller S. O., Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes. Toxicological Sciences 2004 78 2 229 240 2-s2.0-2342428577 10.1093/toxsci/kfh071 (Pubitemid 38559671)
18. Cattley R. C., DeLuca J., Elcombe C., Fenner-Crisp P., Lake B. G., Marsman D. S., Pastoor T. A., Popp J. A., Robinson D. E., Schwetz A. B., Tugwood J., Wahli W., Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Regulatory Toxicology and Pharmacology 1998 27 1 I 47 60 2-s2.0-0031838516 10.1006/rtph.1997.1163 (Pubitemid 28289021)
19. Vanden Heuvel J. P., Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis. Toxicological Sciences 1999 47 1 1 8 2-s2.0-0032962921 10.1093/toxsci/47.1.1 (Pubitemid 29214226)
20. Rakhshandehroo M., Hooiveld G., Müller M., Kersten S., Comparative analysis of gene regulation by the transcription factor PPAR α between mouse and human. PLoS ONE 2009 4 8 2-s2.0-69449086702 10.1371/journal.pone. 0006796 e6796
21. Strijbis K., Vaz F. M., Distel B., Enzymology of the carnitine biosynthesis pathway. IUBMB Life 2010 62 5 357 362 2-s2.0-77953603769 10.1002/iub.323
22. Rebouche C. J., Engel A. G., Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport. Journal of Clinical Investigation 1984 73 3 857 867 2-s2.0-0021362187 (Pubitemid 14156870)
23. Rebouche C. J., Bosch E. P., Chenard C. A., Schabold K. J., Nelson S. E., Utilization of dietary precursors for carnitine synthesis in human adults. Journal of Nutrition 1989 119 12 1907 1913 2-s2.0-0024822538 (Pubitemid 20063884)
24. Stephens F. B., Marimuthu K., Cheng Y., Patel N., Constantin D., Simpson E. J., Greenhaff P. L., Vegetarians have a reduced skeletal muscle carnitine transport capacity. American Journal of Clinical Nutrition 2011 94 3 938 944 2-s2.0-80052011641 10.3945/ajcn.111.012047
25. Rebouche C. J., Lombard K. A., Chenard C. A., Renal adaptation to dietary carnitine in humans. American Journal of Clinical Nutrition 1993 58 5 660 665 2-s2.0-0027442315 (Pubitemid 23319953)
26. Rebouche C. J., Chenard C. A., Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. Journal of Nutrition 1991 121 4 539 546 2-s2.0-0025765643
27. Scaglia F., Wang Y., Longo N., Functional characterization of the carnitine transporter defective in primary carnitine deficiency. Archives of Biochemistry and Biophysics 1999 364 1 99 106 2-s2.0-0033117742 10.1006/abbi.1999.1118 (Pubitemid 29394296)
28. Engel A. G., Rebouche C. J., Wilson D. M., Primary systemic carnitine deficiency. II. Renal handling of carnitine. Neurology 1981 31 7 819 825 2-s2.0-0019445534 (Pubitemid 11087098)
29. Harper P., Elwin C. E., Cederblad G., Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects. European Journal of Clinical Pharmacology 1988 35 5 555 562 2-s2.0-0023756726 (Pubitemid 18264762)
30. Sahajwalla C. G., Helton E. D., Purich E. D., Hoppel C. L., Cabana B. E., Comparison of L-carnitine pharmacokinetics with and without baseline correction following administration of single 30-mg/kg intravenous dose. Journal of Pharmaceutical Sciences 1995 84 5 634 639 2-s2.0-0029041951
31. Brass E. P., Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients. Clinical Therapeutics 1995 17 2 176 185 2-s2.0-0029035063 10.1016/0149-2918(95)80017-4
32. Hiatt W. R., Regensteiner J. G., Wolfel E. E., Ruff L., Brass E. P., Carnitine and acylcarnitine metabolism during exercise in humans. Dependence on skeletal muscle metabolic state. Journal of Clinical Investigation 1989 84 4 1167 1173 2-s2.0-0024441287 (Pubitemid 19247587)
33. Ruff L. J., Miller L. G., Brass E. P., Effect of exogenous carnitine on carnitine homeostasis in the rat. Biochimica et Biophysica Acta 1991 1073 3 543 549 2-s2.0-0025893781 10.1016/0304-4165(91)90228-9
34. Brass E. P., Hoppel C. L., Hiatt W. R., Effect of intravenous L-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans. Clinical Pharmacology and Therapeutics 1994 55 6 681 692 2-s2.0-0028222594 (Pubitemid 24212269)
35. Vukovich M. D., Costill D. L., Fink W. J., Carnitine supplementation: effect on muscle carnitine and glycogen content during exercise. Medicine and Science in Sports and Exercise 1994 26 9 1122 1129 2-s2.0-0027978207 (Pubitemid 24282413)
36. Vaz F. M., Wanders R. J. A., Carnitine biosynthesis in mammals. Biochemical Journal 2002 361 3 417 429 2-s2.0-0036471216 10.1042/0264-6021: 3610417 (Pubitemid 34177810)
37. Fischer M., Keller J., Hirche F., Kluge H., Ringseis R., Eder K., Activities of γ -butyrobetaine dioxygenase and concentrations of carnitine in tissues of pigs. Comparative Biochemistry and Physiology 2009 153 3 324 331 2-s2.0-67349149421 10.1016/j.cbpa.2009.03.005
38. Lahjouji K., Mitchell G. A., Qureshi I. A., Carnitine transport by organic cation transporters and systemic carnitine deficiency. Molecular Genetics and Metabolism 2001 73 4 287 297 2-s2.0-0034842137 10.1006/mgme.2001. 3207 (Pubitemid 32846367)
39. Tein I., Carnitine transport: pathophysiology and metabolism of known molecular defects. Journal of Inherited Metabolic Disease 2003 26 2-3 147 169 2-s2.0-0038042481 (Pubitemid 36889739)
40. Tamai I., Ohashi R., Nezu J. I., Yabuuchi H., Oku A., Shimane M., Sai Y., Tsujit A., Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. Journal of Biological Chemistry 1998 273 32 20378 20382 2-s2.0-0032493741 10.1074/jbc.273.32.20378 (Pubitemid 28377603)
41. Tamai I., Ohashi R., Nezu J. I., Sai Y., Kobayashi D., Oku A., Shimane M., Tsuji A., Molecular and functional characterization of organic cation/carnitine transporter family in mice. Journal of Biological Chemistry 2000 275 51 40064 40072 2-s2.0-0034704135 10.1074/jbc.M005340200 (Pubitemid 32064631)
42. Lahjouji K., Elimrani I., Lafond J., Leduc L., Qureshi I. A., Mitchell G. A., L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2. American Journal of Physiology 2004 287 2 C263 C269 2-s2.0-3242676117 10.1152/ajpcell.00333.2003 (Pubitemid 38955216)
43. Taylor P. M., Absorbing competition for carnitine. Journal of Physiology 2001 532 2 283 2-s2.0-17744366563 10.1111/j.1469-7793.2001.0283f.x (Pubitemid 32390385)
44. Yokogawa K., Higashi Y., Tamai I., Nomura M., Hashimoto N., Nikaido H., Hayakawa J. I., Miyamoto K. I., Tsuji A., Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice. Journal of Pharmacology and Experimental Therapeutics 1999 289 1 224 230 2-s2.0-0032952772 (Pubitemid 29156033)
45. Lamhonwah A. M., Tein I., Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochemical and Biophysical Research Communications 2006 345 4 1315 1325 2-s2.0-33744801418 10.1016/j.bbrc.2006.05.026 (Pubitemid 43833440)
46. Ringseis R., Pösel S., Hirche F., Eder K., Treatment with pharmacological peroxisome proliferator-activated receptor α agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Pharmacological Research 2007 56 2 175 183 2-s2.0-34548126519 10.1016/j.phrs.2007.06.001 (Pubitemid 47302802)
47. Ringseis R., Lüdi S., Hirche F., Eder K., Treatment with pharmacological peroxisome proliferator-activated receptor α agonist clofibrate increases intestinal carnitine absorption in rats. Pharmacological Research 2008 58 1 58 64 2-s2.0-50649085921 10.1016/j.phrs.2008.06.006
48. Luci S., Hirche F., Eder K., Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues. Annals of Nutrition and Metabolism 2008 52 1 58 67 2-s2.0-42149152634 10.1159/000118872 (Pubitemid 351525940)
49. Sülzle A., Hirche F., Eder K., Thermally oxidized dietary fat upregulates the expression of target genes of PPAR α in rat liver. Journal of Nutrition 2004 134 6 1375 1383 2-s2.0-2642574322 (Pubitemid 38720709)
50. Ringseis R., Muschick A., Eder K., Dietary oxidized fat prevents ethanol-induced triacylglycerol accumulation and increases expression of PPAR α target genes in rat liver. Journal of Nutrition 2007 137 1 77 83 2-s2.0-33845996906 (Pubitemid 46052862)
51. Ringseis R., Gutgesell A., Dathe C., Brandsch C., Eder K., Feeding oxidized fat during pregnancy up-regulates expression of PPAR α -responsive genes in the liver of rat fetuses. Lipids in Health and Disease 2007 6, article 6 2-s2.0-33947592794 10.1186/1476-511X-6-6 (Pubitemid 46482317)
52. Koch A., König B., Luci S., Stangl G. I., Eder K., Dietary oxidised fat up regulates the expression of organic cation transporters in liver and small intestine and alters carnitine concentrations in liver, muscle and plasma of rats. British Journal of Nutrition 2007 98 5 882 889 2-s2.0-35148877188 10.1017/S000711450775691X (Pubitemid 47543445)
53. Maeda T., Wakasawa T., Funabashi M., Fukushi A., Fujita M., Motojima K., Tamai I., Regulation of Octn2 transporter (SLC22A5) by peroxisome proliferator activated receptor alpha. Biological and Pharmaceutical Bulletin 2008 31 6 1230 1236 2-s2.0-45749100102 10.1248/bpb.31.1230 (Pubitemid 351871185)
54. Davis A. T., Hoppel C. L., Effect of starvation on the disposition of free and peptide-linked trimethyllysine in the rat. Journal of Nutrition 1986 116 5 760 767 2-s2.0-0022588935 (Pubitemid 16111255)
55. Rebouche C. J., Kinetics, pharmacokinetics, and regulation of L-Carnitine and acetyl-L-carnitine metabolism. Annals of the New York Academy of Sciences 2004 1033 30 41 2-s2.0-10644229056 10.1196/annals.1320.003 (Pubitemid 39656736)
56. Rebouche C. J., Effect of dietary carnitine isomers and γ -butyrobetaine on L-carnitine biosynthesis and metabolism in the rat. Journal of Nutrition 1983 113 10 1906 1913 2-s2.0-0021088859 (Pubitemid 14236237)
57. LaBadie J., Dunn W. A., Aronson N. N., Hepatic synthesis of carnitine from protein bound trimethyl lysine. Lysosomal digestion of methyl lysine labelled asialo fetuin. Biochemical Journal 1976 160 1 85 95 2-s2.0-0017137132
58. Dunn W. A., Rettura G., Seifter E., Englard S., Carnitine biosynthesis from γ -butyrobetaine and from exogenous protein-bound 6-N-trimethyl-L-lysine by the perfused guinea pig liver. Effect of ascorbate deficiency on the in situ activity of γ -butyrobetaine hydroxylase. Journal of Biological Chemistry 1984 259 17 10764 10770 2-s2.0-0021209445 (Pubitemid 14031200)
59. Paul H. S., Adibi S. A., Leucine oxidation and protein turnover in clofibrate-induced muscle protein degradation in rats. Journal of Clinical Investigation 1980 65 6 1285 1293 2-s2.0-0018824076 (Pubitemid 10122369)
60. Ringseis R., Mooren F.-C., Keller J., Couturier A., Wen G., Hirche F., Stangl G. I., Eder K., Krüger K., Regular endurance exercise improves the diminished hepatic carnitine status in mice fed a high-fat diet. Molecular Nutrition and Food Research 2011 55 supplement 2 S193 S202 2-s2.0-80053264450 10.1002/mnfr.201100040
61. Koves T. R., Ussher J. R., Noland R. C., Slentz D., Mosedale M., Ilkayeva O., Bain J., Stevens R., Dyck J. R. B., Newgard C. B., Lopaschuk G. D., Muoio D. M., Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metabolism 2008 7 1 45 56 2-s2.0-37449020075 10.1016/j.cmet.2007.10.013
62. Noland R. C., Koves T. R., Seiler S. E., Lum H., Lust R. M., Ilkayeva O., Stevens R. D., Hegardt F. G., Muoio D. M., Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. Journal of Biological Chemistry 2009 284 34 22840 22852 2-s2.0-69249113803 10.1074/jbc.M109.032888
63. Makowski L., Noland R. C., Koves T. R., Xing W., Ilkayeva O. R., Muehlbauer M. J., Stevens R. D., Muoio D. M., Metabolic profiling of PPAR α -/- mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation. FASEB Journal 2009 23 2 586 604 2-s2.0-59649130350 10.1096/fj.08-119420
64. Luci S., Giemsa B., Kluge H., Eder K., Clofibrate causes an upregulation of PPAR- α target genes but does not alter expression of SREBP target genes in liver and adipose tissue of pigs. American Journal of Physiology 2007 293 1 R70 R77 2-s2.0-34447640129 10.1152/ajpregu.00603.2006 (Pubitemid 47092164)
65. Luci S., König B., Giemsa B., Huber S., Hause G., Kluge H., Stangl G. I., Eder K., Feeding of a deep-fried fat causes PPAR α activation in the liver of pigs as a non-proliferating species. British Journal of Nutrition 2007 97 5 872 882 2-s2.0-34147154245 10.1017/S0007114507669256 (Pubitemid 46561896)
66. Luci S., Giemsa B., Hause G., Kluge H., Eder K., Clofibrate treatment in pigs: effects on parameters critical with respect to peroxisome proliferator-induced hepatocarcinogenesis in rodents. BMC Pharmacology 2007 7, article 6 2-s2.0-34247892466 10.1186/1471-2210-7-6 (Pubitemid 46696443)
67. Ringseis R., Wege N., Wen G., Rauer C., Hirche F., Kluge H., Eder K., Carnitine synthesis and uptake into cells are stimulated by fasting in pigs as a model of nonproliferating species. Journal of Nutritional Biochemistry 2009 20 11 840 847 2-s2.0-71749092757 10.1016/j.jnutbio.2008.07.012
68. Ringseis R., Luci S., Spielmann J., Kluge H., Fischer M., Geissler S., Wen G., Hirche F., Eder K., Clofibrate treatment up-regulates novel organic cation transporter (OCTN)-2 in tissues of pigs as a model of non-proliferating species. European Journal of Pharmacology 2008 583 1 11 17 2-s2.0-39649106879 10.1016/j.ejphar.2008.01.008
69. Yu S., Reddy J. K., Transcription coactivators for peroxisome proliferator-activated receptors. Biochimica et Biophysica Acta 2007 1771 8 936 951 2-s2.0-34547604561 10.1016/j.bbalip.2007.01.008 (Pubitemid 47198542)
70. Litherland N. B., Bionaz M., Wallace R. L., Loor J. J., Drackley J. K., Effects of the peroxisome proliferator-activated receptor- α agonists clofibrate and fish oil on hepatic fatty acid metabolism in weaned dairy calves1. Journal of Dairy Science 2010 93 6 2404 2418 2-s2.0-77953008197 10.3168/jds.2009-2716
71. Bionaz M., Baumrucker C. R., Shirk E., Vanden Heuvel J. P., Block E., Varga G. A., Short communication: characterization of Madin-Darby bovine kidney cell line for peroxisome proliferator-activated receptors: temporal response and sensitivity to fatty acids. Journal of Dairy Science 2008 91 7 2808 2813 2-s2.0-47149101994 10.3168/jds.2007-0789 (Pubitemid 351976602)
72. Bionaz M., Thering B. J., Loor J. J., Fine metabolic regulation in ruminants via nutrient-gene interactions: saturated long-chain fatty acids increase expression of genes involved in lipid metabolism and immune response partly through PPAR- α activation. British Journal of Nutrition 2012 107 2 179 191 2-s2.0-82155184140 10.1017/S0007114511002777
73. Loor J. J., Dann H. M., Everts R. E., Oliveira R., Green C. A., Janovick Guretzky N. A., Rodriguez-Zas S. L., Lewin H. A., Drackley J. K., Temporal gene expression profiling of liver from periparturient dairy cows reveals complex adaptive mechanisms in hepatic function. Physiological Genomics 2005 23 2 217 226 2-s2.0-33645794065 10.1152/physiolgenomics.00132.2005 (Pubitemid 44437980)
74. Loor J. J., Dann H. M., Janovick Guretzky N. A., Everts R. E., Oliveira R., Green C. A., Litherland N. B., Rodriguez-Zas S. L., Lewin H. A., Drackley J. K., Plane of nutrition prepartum alters hepatic gene expression and function in dairy cows as assessed by longitudinal transcript and metabolic profiling. Physiological Genomics 2006 27 1 29 41 2-s2.0-33749442896 10.1152/ physiolgenomics.00036.2006 (Pubitemid 44511823)
75. Loor J. J., Everts R. E., Bionaz M., Dann H. M., Morin D. E., Oliveira R., Rodriguez-Zas S. L., Drackley J. K., Lewin H. A., Nutrition-induced ketosis alters metabolic and signaling gene networks in liver of periparturient dairy cows. Physiological Genomics 2007 32 1 105 116 2-s2.0-37549011823 10.1152/physiolgenomics.00188.2007
76. Loor J. J., Genomics of metabolic adaptations in the peripartal cow. Animal 2010 4 7 1110 1139 2-s2.0-77954503824 10.1017/S1751731110000960
77. Grum D. E., Drackley J. K., Younker R. S., LaCount D. W., Veenhuizen J. J., Nutrition during the dry period and hepatic lipid metabolism of periparturient dairy cows. Journal of Dairy Science 1996 79 10 1850 1864 2-s2.0-0030253703 (Pubitemid 126428977)
78. Carlson D. B., Woodworth J. C., Drackley J. K., Effect of L-carnitine infusion and feed restriction on carnitine status in lactating Holstein cows. Journal of Dairy Science 2007 90 5 2367 2376 2-s2.0-35748936443 10.3168/jds.2006-605 (Pubitemid 350045360)
79. Schlegel G., Keller J., Hirche F., Geiler S., Schwarz F. J., Ringseis R., Stangl G. I., Eder K., Expression of genes involved in hepatic carnitine synthesis and uptake in dairy cows in the transition period and at different stages of lactation. BMC Veterinary Research 2012 8, article 28 2-s2.0-84858059373 10.1186/1746-6148-8-28
80. Cogburn L. A., Porter T. E., Duclos M. J., Simon J., Burgess S. C., Zhu J. J., Cheng H. H., Dodgson J. B., Burnside J., Functional genomics of the chicken-a model organism. Poultry Science 2007 86 10 2059 2094 2-s2.0-35348826030 (Pubitemid 47580859)
81. Diot C., Douaire M., Characterization of a cDNA sequence encoding the peroxisome proliferator activated receptor α in the chicken. Poultry Science 1999 78 8 1198 1202 2-s2.0-0033173081 (Pubitemid 129555937)
82. Meng H., Li H., Zhao J. G., Gu Z. L., Differential expression of peroxisome proliferator-activated receptors alpha and gamma gene in various chicken tissues. Domestic Animal Endocrinology 2005 28 1 105 110 2-s2.0-11144331451 10.1016/j.domaniend.2004.05.003 (Pubitemid 40020320)
83. König B., Kluge H., Haase K., Brandsch C., Stangl G. I., Eder K., Effects of clofibrate treatment in laying hens. Poultry Science 2007 86 6 1187 1195 2-s2.0-34547686733 (Pubitemid 47580994)
84. Shibani M., Keller J., König B., Effects of activation of peroxisome proliferator-activated receptor- α by clofibrate on carnitine homeostasis in laying hens. African Journal of Agricultural Research 2012 7 10 1450 1455
85. Shibani M., Keller J., König B B., Effects of natural agonists of peroxisome proliferator-activated receptor α on carnitine homeostasis in laying hens. British Poultry Science. In press
86. Suzuki M., Tokuyama K., Kinoshita M., Urinary profile of L-carnitine and its derivatives in starved normal persons and ACTH injected patients with myopathy. Journal of Nutritional Science and Vitaminology 1983 29 3 303 312 2-s2.0-0020955314 (Pubitemid 13047224)
87. Border J. R., Burns G. P., Rumph C., Schenk W. G., Carnitine levels in severe infection and starvation: a possible key to the prolonged catabolic state. Surgery 1970 68 1 175 179 2-s2.0-0014825246
88. D'Argenio G., Petillo O., Margarucci S., Torpedine A., Calarco A., Koverech A., Boccia A., Paolella G., Peluso G., Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor γ in humans and mice and contributes to local and systemic carnitine homeostasis. Journal of Biological Chemistry 2010 285 35 27078 27087 2-s2.0-77956254249 10.1074/jbc.M110.109678
89. Holst D., Luquet S., Nogueira V., Kristiansen K., Leverve X., Grimaldi P. A., Nutritional regulation and role of peroxisome proliferator-activated receptor δ in fatty acid catabolism in skeletal muscle. Biochimica et Biophysica Acta 2003 1633 1 43 50 2-s2.0-0038460823 10.1016/S1388-1981(03)00071- 4 (Pubitemid 36773945)
90. Gilde A. J., Van der Lee K. A. J. M., Willemsen P. H. M., Chinetti G., Van der Leij F. R., Van der Vusse G. J., Staels B., Van Bilsen M., Peroxisome proliferator-activated receptor (PPAR) α and PPAR β / δ but not PPAR γ modulate the expression of genes involved in cardiac lipid metabolism. Circulation Research 2003 92 5 518 524 2-s2.0-0037459358 10.1161/01.RES.0000060700.55247.7C (Pubitemid 36368664)
91. Gutgesell A., Wen G., König B., Koch A., Spielmann J., Stangl G. I., Eder K., Ringseis R., Mouse carnitine-acylcarnitine translocase (CACT) is transcriptionally regulated by PPAR α and PPAR δ in liver cells. Biochimica et Biophysica Acta 2009 1790 10 1206 1216 2-s2.0-69949098108 10.1016/j.bbagen.2009.06.012